DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS

Drug Device Combination Products Market, By Products (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, and Other Products), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centre’s, and Other End User), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)

Published In : Jul 2023
Code : CMI3919
Pages :278
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Drug Device Combination Product Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global drug device combination product market over the forecast period. North America is estimated to hold 40.51% of the market share in 2030.

Global Drug Device Combination Product Market- Cross Sectional Analysis

Among products type, Drug eluting stents (DES) held a dominant position in North America region over the forecast period due to increasing number of inorganic growth strategies such as collaboration and others by the market players for product development. For instance, 13 May, 2022, Medtronic plc, a global leader in healthcare technology, announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier drug-eluting stent (DES).

Geographies covered: North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC, Israel, and Rest of Middle East, South Africa, North Africa, and Central Africa